Methods and systems for determining fluid content of tissue

• US 8,989,837 B2
• Filed: 04/14/2010
• Issued: 03/24/2015
• Est. Priority Date: 12/01/2009
• Status: Active Grant

• Current Assignee: ZOLL Medical Israel Limited (Asahi Kasei Corporation)
• Original Assignee: Kyma Medical Technologies Ltd. (Asahi Kasei Corporation)
• Inventors: Weinstein, Uriel, Bernstein, Assaf, Cohen, Eyal
• Primary Examiner(s): REMALY, MARK DONALD
• Application Number:
  US12/759,715
• Publication Number:
  US 20110130800A1
• Time in Patent Office: 1,805 Days
• Field of Search: 600/407, 600437-472
• US Class Current: 600/407
• CPC Class Codes: A61B 2560/0412 Low-profile patch shaped housings
• CPC Class Codes: A61B 2562/0217 Electrolyte containing
• CPC Class Codes: A61B 2562/14 Coupling media or elements to improve sensor contact with skin or tissue
• CPC Class Codes: A61B 2562/166 the sensor is mounted on a specially adapted printed circuit board
• CPC Class Codes: A61B 5/0507 using microwaves or terahertz waves
• CPC Class Codes: A61B 5/061 Determining position of a probe within the body employing means separate from the probe, e.g. sensing internal probe position employing impedance electrodes on the surface of the body A61B1/00158 takes precedence
• CPC Class Codes: A61B 5/6823 Trunk, e.g., chest, back, abdomen, hip
• CPC Class Codes: A61B 8/085 for locating body or organic structures, e.g. tumours, calculi, blood vessels, nodules
• CPC Class Codes: A61B 8/4254 using sensors mounted on the probe
• CPC Class Codes: A61N 1/36578 controlled by mechanical motion of the heart wall, e.g. measured by an accelerometer or microphone

Abstract

Embodiments of the subject application include a diagnostic apparatus including one or more antennas disposed on a thorax of a living body to direct radio frequency (RF) electromagnetic waves through tissue and output signals responsively to the waves that have passed through the tissue. The apparatus may also include processing circuitry configured to process the signals over time so as to measure one or more RF path characteristics of the RF electromagnetic waves. The RF path length may be defined by a length of time required for the RF waves to pass through the thorax to an antenna and/or pass to tissue and reflect therefrom to an antenna, based on the path characteristic to assess a fluid content of the tissue.

Claims

1. A diagnostic apparatus, comprising:

one or more antennas configured to be disposed on a thorax of a body of a patient so as to direct radio frequency (RF) electromagnetic waves through a lung in the body and to output signals responsively to the RF electromagnetic waves that have passed through the lung; and

processing circuitry is configured to;

process the signals to determine an effective RF path length of the RF electromagnetic waves,

wherein the effective RF path length is defined by the length of time required for the RF electromagnetic waves to pass through at least one of the thorax to an antenna and pass through to the lung and reflect therefrom to an antenna,

compare the effective RF path length to one or more stored RF path length values corresponding to identified levels of fluid content of lungs, and

determine fluid content of the lung based on the comparison.

2. The apparatus according to claim 1, wherein the processing circuitry is further configured to measure a change in the effective RF path length over one or more respiratory cycles of the lung, and to assess the fluid content responsively to the change.

3. The apparatus according to claim 1, wherein the processing circuitry is further configured to receive a measure of a physical distance traversed by the RF electromagnetic waves through the thorax and compare the effective RF path length to the physical distance.

4. The apparatus according to claim 1, wherein the one or more antennas comprise a transmitting antenna at a first location on a first side of the thorax, which transmits the RF electromagnetic waves through the lung, and a receiving antenna, which receives the RF electromagnetic waves that have passed through the lung at a second location on a second side of the thorax, opposite the first side, and wherein the physical distance is measured between the first and second locations.

5. The apparatus according to claim 1, wherein the one or more antennas comprise at least one antenna that is configured to direct the RF electromagnetic waves through the lung toward a heart in the body, and to output the signals responsively to the RF electromagnetic waves reflected from the heart.

6. The apparatus according to claim 5, further comprising an ultrasonic transducer, which is adjacent to the at least one antenna and is configured to direct ultrasonic waves toward the heart and receive the ultrasonic waves reflected from the heart so as to provide a measure of the physical distance.

7. The apparatus according to claim 1, wherein the stored values comprise RF path lengths for at least one of healthy lungs, edematous lungs, and previous effective RF path length measurements made on the patient.

8. A method for diagnosis, comprising:

directing radio frequency (RF) electromagnetic waves from one or more antennas disposed on a thorax of a body of a patient so that the RF electromagnetic waves pass through or reflect off a lung in the body;

outputting signals responsively to the RF electromagnetic waves that have passed through the lung;

processing the signals over time so as to measure an effective RF path length of the RF electromagnetic waves, wherein the effective RF path length is defined by a length of time required for the RF electromagnetic waves to pass through at least one of the thorax to an antenna and pass through to the lung and reflect therefrom to an antenna;

comparing the measured effective RF path length to one or more stored RF path length values corresponding to identified levels of fluid content of lungs; and

determining fluid content of the lung based on the comparison.

9. The method according to claim 8, wherein processing the signals further comprises measuring a change in the effective RF path length over one or more respiratory cycles of the lung, and assessing the fluid content responsively to the change.

10. The method according to claim 8, further comprising measuring a physical distance traversed by the RF electromagnetic waves through the thorax, and comparing the effective RF path length to the physical distance.

11. The method according to claim 10, wherein the one or more antennas comprise a transmitting antenna at a first location on a first side of the thorax, which transmits the RF electromagnetic waves through the lung, and a receiving antenna, which receives the RF electromagnetic waves that have passed through the lung at a second location on a second side of the thorax, opposite the first side, and wherein the physical distance is measured between the first and second locations.

12. The method according to claim 8, wherein the one or more antennas comprise at least one antenna that is configured to direct the RF electromagnetic waves through the lung toward a heart in the body, and wherein the method further comprises outputting signals responsively to the RF electromagnetic waves reflected from the heart.

13. The method according to claim 12, further comprising directing ultrasonic waves toward the heart and receiving the ultrasonic waves reflected from the heart at a location adjacent to the at least one antenna so as to provide a measure of the physical distance.

14. The method according to claim 8, wherein the stored values comprise RF path lengths for at least one of healthy lungs, edematous lungs, and previous effective RF path length measurements made on the patient.